B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Clinical trials for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) explained in plain language.

Never miss a new study

Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear

Sign up with your email to follow new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet finished but already full! 1

New drug tested for tough blood cancers that resist treatment

Disease control Ongoing

This is a first-in-human study to find a safe dose and schedule for an experimental drug called PIT565. It is for adults with advanced B-cell non-Hodgkin lymphoma or B-cell acute lymphoblastic leukemia that has returned or not responded to at least two prior treatments. The main …

Matched conditions: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 27, 2026 12:38 UTC

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)

Get alerted when new B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) trials appear

New drug tested for tough blood cancers that resist treatment